menu
    • menu

    Company profile for Athersys

    NEW Drugs in Dev: 3
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Athersys is a clinical-stage biotechnology company developing novel and proprietary best-in-class therapies designed to extend and enhance the quality of human life. Our focus is on the treatment of medical conditions where there is significant clinical need, and we are particularly focused on developing therapies in the regenerative medicine area. We are developing MultiStem®, a patented, adult-derived "off-the-shelf" stem c...
    Athersys is a clinical-stage biotechnology company developing novel and proprietary best-in-class therapies designed to extend and enhance the quality of human life. Our focus is on the treatment of medical conditions where there is significant clinical need, and we are particularly focused on developing therapies in the regenerative medicine area. We are developing MultiStem®, a patented, adult-derived "off-the-shelf" stem cell therapy platform, for disease indications in areas of neurological, inflammatory & immune, and cardiovascular disease areas, as well as other critical care indications where there is substantial unmet medical need du

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AthersysUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    CONTACT Athersys, Inc. 3201 Carnegie Avenue Cleveland, OH 44115
    Telephone
    Telephone
    216-431-9900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.athersys.com/home/default.aspx
    Linkedin
    Linkedin
    https://www.linkedin.com/company/athersys?trk=top_nav_home
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/athersys

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BioProcess International US West

    Not Confirmed

    envelop Contact Supplier

    BioProcess International US West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Athersys files for Chapter 11 bankruptcy, sells everything to partner Healios
    Athersys files for Chapter 11 bankruptcy, sells everything to partner Healios

    09 Jan 2024

    // Ayisha Sharma ENDPTS

    https://endpts.com/athersys-files-for-chapter-11-bankruptcy-sells-everything-to-partner-healios/

    Ayisha Sharma ENDPTS
    09 Jan 2024
    Share Share
    Athersys files for bankruptcy, sells assets to Healios
    Athersys files for bankruptcy, sells assets to Healios

    09 Jan 2024

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles

    James Waldron FIERCE BIOTECH
    09 Jan 2024
    Share Share
    Athersys Reports Third Quarter 2023 Financial Results and Business Highlights
    Athersys Reports Third Quarter 2023 Financial Results and Business Highlights

    16 Nov 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231115819414/en

    BUSINESSWIRE
    16 Nov 2023
    Share Share
    Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement
    Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement

    16 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231016359283/en

    BUSINESSWIRE
    16 Oct 2023
    Share Share
    Athersys Reports Analysis Results of MASTERS-2 Clinical Study with MultiStem
    Athersys Reports Analysis Results of MASTERS-2 Clinical Study with MultiStem

    10 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231010500674/en

    BUSINESSWIRE
    10 Oct 2023
    Share Share
    Athersys nears bankruptcy as cell therapy fails interim analysis
    Athersys nears bankruptcy as cell therapy fails interim analysis

    10 Oct 2023

    // Annalee Armstrong FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/athersys-inches-closer-bankruptcy-stroke-cell-therapy-fails-interim-analysis

    Annalee Armstrong FIERCE BIOTECH
    10 Oct 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search